Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 19.68M | $416.0M | 17.35% | +3.31M | 2026-06-30 |
| FMR LLC | 16.99M | $359.0M | 14.98% | +17.6K | 2026-06-30 |
| BlackRock, Inc. | 8.81M | $186.0M | 7.77% | +636.8K | 2026-06-30 |
| State Street Corp | 5.49M | $116.0M | 4.85% | +94.7K | 2026-06-30 |
| Wellington Management Group LLP | 5.21M | $110.0M | 4.59% | +478.2K | 2026-06-30 |
| Redmile Group, LLC | 4.91M | $104.0M | 4.33% | -647.3K | 2026-06-30 |
| Primecap Management Co | 4.58M | $97.0M | 4.04% | -206.8K | 2026-06-30 |
| Vanguard Capital Management LLC | 4.55M | $96.0M | 4.01% | +121.6K | 2026-06-30 |
| Driehaus Capital Management LLC | 4.35M | $92.0M | 3.83% | +246.2K | 2026-06-30 |
| Enavate Sciences GP, LLC | 3.61M | $76.0M | 3.19% | -- | 2026-06-30 |
